Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Turnbull

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
JAMA|February 17, 2025
Platform Trials in ALSJohn Turnbull
The New England Journal of Medicine|December 2, 2020
Sodium Phenylbutyrate-Taurursodiol for ALSJohn Turnbull
The Lancet. Neurology|August 22, 2020
Reappraisal of an ALS trial: unaccounted procedural riskJohn Turnbull
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 11, 2019
Author response to a Letter to the Editor entitled: Edaravone administration in pivotal clinical study 19 (Authors: Genge, Angela; Brooks, Benjamin)John Turnbull
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 19, 2014
Why is ALS so Difficult to Treat?John Turnbull
Health Estate|November 19, 2003
Addressing areas of common concernJohn Turnbull
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 31, 2018
Is edaravone harmful? (A placebo is not a control)John Turnbull
Journal of Molecular Neuroscience : MN|October 8, 2011
Sonic hedgehog is cytoprotective against oxidative challenge in a cellular model of amyotrophic lateral sclerosisRandy Peterson, John Turnbull
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 13, 2010
Supporting choice in health care for people with learning disabilitiesJohn Turnbull, Sue Chapman
Journal of Nursing Management|June 13, 2003
The creativity challengeJohn Turnbull, Carole Andrews
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
JAMA|February 17, 2025
Platform Trials in ALSJohn Turnbull
The New England Journal of Medicine|December 2, 2020
Sodium Phenylbutyrate-Taurursodiol for ALSJohn Turnbull
The Lancet. Neurology|August 22, 2020
Reappraisal of an ALS trial: unaccounted procedural riskJohn Turnbull
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 11, 2019
Author response to a Letter to the Editor entitled: Edaravone administration in pivotal clinical study 19 (Authors: Genge, Angela; Brooks, Benjamin)John Turnbull
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 19, 2014
Why is ALS so Difficult to Treat?John Turnbull
Health Estate|November 19, 2003
Addressing areas of common concernJohn Turnbull
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 31, 2018
Is edaravone harmful? (A placebo is not a control)John Turnbull
Journal of Molecular Neuroscience : MN|October 8, 2011
Sonic hedgehog is cytoprotective against oxidative challenge in a cellular model of amyotrophic lateral sclerosisRandy Peterson, John Turnbull
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 13, 2010
Supporting choice in health care for people with learning disabilitiesJohn Turnbull, Sue Chapman
Journal of Nursing Management|June 13, 2003
The creativity challengeJohn Turnbull, Carole Andrews
Pageof 5